계명대학교 의학도서관 Repository

Impact of Tacrolimus Trough Level in Kidney Transplant Recipients on the Post-transplant Clinical Outcome

Metadata Downloads
Author(s)
박우영강성식박성배진규복한승엽
Alternative Author(s)
Park, Woo YoungKang, Seong SikPark, Sung BaeJin, Kyu BokHan, Seung Yeup
Issued Date
2018
Abstract
INTRODUCTION AND AIMS: Tacrolimus is a main maintenance immunosuppressant in kidney transplantation (KT), and the level at the early period after KT is very important for the prognosis of allograft. However, the common criteria of tacrolimus trough level (TTL) are uncertain. We investigated the impact of TTL in KT recipients on the post-transplant clinical outcome.

METHODS: We retrospectively investigated the patients performed KT between July 2007 and June 2016. We investigated TTLs at 1 week, 2 week, 3 week, 1 month, 3 months, 6 months and 12 months after KT. We evaluated the incidence of acute rejection and cytomegalovirus (CMV) infection, and graft survival according to the TTLs.

RESULTS: A total of 429 patients who received KT during the study period were enrolled. The mean age of KTRs was 46.3 ± 11.5 years and male was 55.5%. TTLs (ng/mL) at 1 week, 2 week, 3 week, 1 month, 3 months, 6 months and 12 months after KT were 6.2 (5.0 - 7.9), 7.1 (5.8 - 8.6), 7.8 (6.3 - 9.6), 7.6 (6.0 - 9.5), 6.8 (5.5 - 8.4), 6.5 (5.2 - 7.8), and 5.9 (4.8 - 7.1). The incidence of acute rejection within 1 year after KT was significantly higher when TTLs at 3 months was less than 4.0 ng/mL (P = 0.020). On the contrary, the incidence of CMV infection after 1 year was significantly higher when TTLs at 12 months was 10 ng/mL or more (P = 0.015). However, the incidence of CMV infection within 1 year was not associated with TTL within 1 year. Death-censored graft survival rate was significantly lower in KTRs with acute rejection and CMV infection (P < 0.001 and 0.008). In multivariate analysis, TTL less than 4 ng/mL at 3 months after KT was an independent risk factor for graft failure.

CONCLUSIONS: Acute rejection and CMV infection are important risk factors for allograft failure. Therefore, TTL should be kept at least 4 ng/mL or more at 3 months after KT to reduce the incidence of acute rejection within 1 year after KT and below 10 ng/mL since 1 year after KT to reduce the incidence of CMV infection since 1 year after KT.
Department
Kidney Institute (신장연구소)
Dept. of Internal Medicine (내과학)
Publisher
School of Medicine (의과대학)
Citation
Nephrology Dialysis Transplantation, Vol.33(suppl.1_1) : SP-752, 2018
Type
Article
ISSN
0931-0509
DOI
10.1093/ndt/gfy104.SP752
URI
http://kumel.medlib.dsmc.or.kr/handle/2015.oak/41292
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
3. Research Institutues (연구소) > Kidney Institute (신장연구소)
Authorize & License
  • AuthorizeOpen
Files in This Item:

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.